Loading...

Check-Cap Ltd.

CHEKNASDAQ
Healthcare
Medical - Diagnostics & Research
$0.76
$0.01(1.46%)

Check-Cap Ltd. (CHEK) Company Profile & Overview

Explore Check-Cap Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Check-Cap Ltd. (CHEK) Company Profile & Overview

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOYoav Kimchy

Contact Information

972 4 830 3401
Check-Cap Building, Isfiya, 30090

Company Facts

85 Employees
IPO DateMar 4, 2015
CountryIL
Actively Trading

Frequently Asked Questions

;